Study of WP1220 for the Treatment of Adult Subjects With Cutaneous T-Cell Lymphoma (CTCL)
Clinical trial NCT04702503 · COMPLETED
Trial details
- NCT number
- NCT04702503
- Sponsor
- Moleculin Biotech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-08
- Primary completion
- 2019-11-15
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.